These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10431156)

  • 1. Naturally occurring antibodies to cholesterol: a new theory of LDL cholesterol metabolism.
    Alving CR; Wassef NM
    Immunol Today; 1999 Aug; 20(8):362-6. PubMed ID: 10431156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linkage between cholesterol 7alpha-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations.
    Wang J; Freeman DJ; Grundy SM; Levine DM; Guerra R; Cohen JC
    J Clin Invest; 1998 Mar; 101(6):1283-91. PubMed ID: 9502769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of plasma levels of low-density lipoprotein cholesterol: interpretation of data on low-density lipoprotein turnover in man.
    Meddings JB; Dietschy JM
    Circulation; 1986 Oct; 74(4):805-14. PubMed ID: 3757192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E competitively inhibits receptor-dependent low density lipoprotein uptake by the liver but has no effect on cholesterol absorption or synthesis in the mouse.
    Woollett LA; Osono Y; Herz J; Dietschy JM
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12500-4. PubMed ID: 8618929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against low-density lipoprotein and atherogenic potential of blood.
    Kacharava AG; Tertov VV; Orekhov AN
    Ann Med; 1993 Dec; 25(6):551-5. PubMed ID: 8292305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of anti-LDL receptor antibody on the transfer of cholesterol from LDL to isolated lymphocytes in normal subjects.
    Iwata S; Sakuma N; Hibino T; Sato T; Yoneyama A; Kamiya Y; Kawaguchi M; Fujinami T; Kunimatsu M
    Clin Biochem; 1995 Jun; 28(3):309-11. PubMed ID: 7554251
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased levels of anti-oxidized low-density lipoprotein antibodies are associated with reduced levels of cholesterol in the general population.
    Tinahones FJ; Gómez-Zumaquero JM; Rojo-Martínez G; Cardona F; Esteva de Antonio IE; Ruiz de Adana MS; Soriguer FJ
    Metabolism; 2002 Apr; 51(4):429-31. PubMed ID: 11912548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune hyperlipidemia with inhibitory monoclonal antibodies against low density lipoprotein binding to fibroblasts in a case with multiple myeloma.
    Nozaki S; Ito Y; Nakagawa T; Yamashita S; Sasaki J; Matsuzawa Y
    Intern Med; 1997 Dec; 36(12):920-5. PubMed ID: 9475252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of autoantibodies against oxidatively modified low density lipoproteins during long-term LDL-apheresis.
    Turk Z; Mrzljak V; Turk N; Metelko Z
    Diabetes Nutr Metab; 1999 Dec; 12(6):413-7. PubMed ID: 10782563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile acids regulate hepatic low density lipoprotein receptor activity in the hamster by altering cholesterol flux across the liver.
    Spady DK; Stange EF; Bilhartz LE; Dietschy JM
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1916-20. PubMed ID: 3456612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
    Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein receptors.
    Lestavel S; Fruchart JC
    Cell Mol Biol (Noisy-le-grand); 1994 Jun; 40(4):461-81. PubMed ID: 8061563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein fractions and receptors: a role for probucol?
    Bilheimer DW
    Am J Cardiol; 1986 Jun; 57(16):7H-15H. PubMed ID: 3637051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of monocyte macrophages stimulation on hepatic lipoprotein receptors.
    Cai HJ; He ZG; Ding YN
    Biochim Biophys Acta; 1988 Feb; 958(3):334-42. PubMed ID: 2829970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theoretical considerations of what regulates low-density-lipoprotein and high-density-lipoprotein cholesterol.
    Dietschy JM
    Am J Clin Nutr; 1997 May; 65(5 Suppl):1581S-1589S. PubMed ID: 9129498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human hepatic low-density lipoprotein receptors: associations of receptor activities in vitro with plasma lipid and apolipoprotein concentrations in vivo.
    Nanjee MN; Miller NE
    Biochim Biophys Acta; 1989 Apr; 1002(2):245-55. PubMed ID: 2495023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding and metabolism of low-density lipoprotein by skin fibroblasts of fetuses and newborns with anencephaly.
    Carr BR; Parker CR
    Am J Obstet Gynecol; 1987 Dec; 157(6):1351-5. PubMed ID: 3425642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic characteristics and mechanisms of regulation of receptor-dependent and receptor-independent LDL transport in the liver of different animal species and humans.
    Meddings JB; Spady DK; Dietschy JM
    Am Heart J; 1987 Feb; 113(2 Pt 2):475-81. PubMed ID: 3812205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse.
    Osono Y; Woollett LA; Herz J; Dietschy JM
    J Clin Invest; 1995 Mar; 95(3):1124-32. PubMed ID: 7883961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of hepatic cholesterol metabolism in man.
    Angelin B
    Ann Med; 1991 Apr; 23(2):177-80. PubMed ID: 1906288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.